Correction: A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM (Frontiers in Immunology, (2022), 13, (1044743), 10.3389/fimmu.2022.1044743)

Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders The Conflict of interest statement was erroneously given as: “RW is a named inventor on IP covering the use of nanophosphors in lateral flow assays, and may receive income from its commercialization by Clip Health, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest”. The correct Conflict of interest statement is “RW is a named inventor on IP covering the use of nanophosphors in lateral flow assays, and may receive income from its commercialization by Clip Health, Inc. Authors RW, KK and BV acknowledge their financial interest in Glow Nanotech which at the time was developing a different LFA technology. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest”. The original version of this article has been updated.